The Guardian’s “Poverty Matters Blog” examines how the government of Benin “is making headway in attempts to reduce deaths from malaria” by cracking down on counterfeit treatments, offering malaria treatment free-of-charge in public clinics and hospitals, and creating “an army of ordinary citizens in the battle against preventable diseases like malaria.” The article describes a UNICEF-supported program that trains and employs local residents as community health extension workers, who often serve as the front line in providing treatment for malaria or maternal and child health care (Smith, 2/10).
Access to Health Services
Proposed Intellectual Property Agreement Between E.U., India Could Affect Generic Drug Exports, Advocacy Groups Say
The Independent examines how “[t]he cheap supply of antiretroviral drugs to people with AIDS across the world could be choked by an ‘intellectual property’ deal … being negotiated [on Friday] at the 12th E.U.-India summit in New Delhi between the President of the European Commission, JosÃ© Manuel Barroso, and the Indian Prime Minister Dr. Manmohan Singh.”
“The health of millions of indigenous people across Asia is at risk, experts say, as lack of recognition of their legal status hinders data collection, making their medical problems invisible in most national health surveys,” IRIN reports. “Indigenous peoples — defined by the U.N. as people with ancestral ties to a geographical region who retain ‘distinct characteristics’ from other parts of the population — rank disproportionately high in most indicators of poor health, according to the U.N. Secretariat Department of Economic and Social Affairs,” the news service adds.
NewsOne examines HIV in the Caribbean, where one percent of the population is infected with the virus, “small in comparison to numbers found in the global scheme but significant enough to distinguish it as the second-highest region with HIV/AIDS outside of sub-Saharan Africa.” According to the article, HIV is spread primarily among populations at high risk for the disease, including sex workers, men who have sex with men, and people who use injection drugs.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, “men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs,” Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding “Targeting men in prevention and treatment … may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa.” They note that in Africa, fewer men than women access antiretroviral therapy (ART), and men “typically have higher mortality,” seek care later in the disease, and “are more likely to be lost to follow-up.”
In this post in USAID’s “IMPACTblog,” Ed Scholl, AIDSTAR-One project director, writes about HIV and tuberculosis (TB) care in Brazil, where “USAID has partnered with the Brazilian Ministry of Health to improve early TB detection, increase HIV counseling and testing, and provide medical treatment for both infections.” He continues, “AIDSTAR-One, a USAID-funded project, is also conducting outreach in Brazilian prisons, which are often at high risk of TB and HIV epidemics.” He concludes, “Through partnerships like USAID and AIDSTAR-One, we can effectively fight TB and HIV across Brazil and Latin America, to improve the health of countless people and ultimately save lives” (2/7).
“An expanding network of eye clinics has found an innovative way of providing quality, affordable treatment to millions of blind and visually impaired poor people in India,” the Guardian’s “Poverty Matters” blog reports. The LV Prasad Eye Institute (LVPEI), a not-for-profit organization that runs a chain of 82 eye care centers and a research institute in India, uses tiered pricing to charge wealthier patients for treatment, allowing the group to provide free treatment to poorer patients.
U.N. Says Asia Pacific Region Making Strides Against HIV/AIDS, Must Address Social And Legal Barriers To Treatment, Prevention
The U.N. Economic and Social Commission for the Asia Pacific (ESCAP) on Monday in Bangkok “opened a three-day meeting lauding impressive gains in recent years in the fight against HIV/AIDS,” but the body cautioned “there are still legal and social barriers that significantly set back eradication efforts,” VOA News reports. U.N. ESCAP Executive Secretary Noeleen Heyzer “note[d] the gains are uneven and there are still gaps in the goal of universal access to HIV treatment,” the news service writes.
President Barack Obama’s December 1 World AIDS Day speech “could be pivotal, but only if it is followed by changes in how we tackle global AIDS,” Chris Collins, vice president and director of public policy at amfAR, The Foundation for AIDS Research, writes in this Huffington Post “Global Motherhood” opinion piece. “Obama signaled a renewed U.S. commitment to funding for global AIDS programs at a time when resources at home are constrained and other countries are backing away from the fight,” he writes, adding, “Now it’s time to plot a course for implementing the president’s vision.”
In this post in the Guardian’s “The Observer,” Mark Honigsbaum, a research associate at the University of Zurich’s Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague FranÃ§ois LÃ©vesque “have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the” sweet wormwood plant from which it is extracted. Honigsbaum notes that “extracting artemisinin is expensive and because it takes time to cultivate the plant there are often bottlenecks in supply,” and writes, “Their discovery has the potential to make the drug more affordable for the 225 million people affected by malaria every year” (2/4).